Skip to main content
Photo of Priyanka Vashisht

Priyanka Vashisht

Adjunct Assistant Professor

Internal Medicine | College of Medicine

Education/Credentials
  • Bachelor's Degree: Maulana Azad Medical College
  • Residency: Delhi University
  • Residency: LNR Foundation School
  • Residency: Creighton University
  • Fellowship: University of Nebraska
Board Certifications & Licenses

American Board of Internal Medicine (Certification Date: 20120815)
American Board of Internal Medicine (Rheumatology) (Certification Date: 20161013)

Specialties

Internal Medicine
Rheumatology

Contact Information

Clinical Interests

Internal Medicine

Ankylosing Spondylitis

Autoimmune Vasculitis

Behcet Syndrome (Neuro-Bechet)

Central Nervous System Lupus Vasculitis

Collagen Disease

CREST Syndrome

Cryoglobulinemia

Cutaneous, Leukocytoclastic, Vasculitis

Gout

Hip Rheumatoid Arthritis

Lupus (Systemic lupus erythematosus)

Lupus Erythematosus Panniculitis

Lupus Nephritis

Microscopic Polyangiitis

Mixed Connective Tissue Disease (MCTD)

Osteochondritis Dissecans

Overlap Connective Tissue Disease

Paget Disease

Polymyalgia Rheumatica

Polymyositis

Polymyositis/Dermatomyositis

Pseudogout

Psoriatic Arthritis

Raynaud Phenomenon in Scleroderma

Raynaud's Disease

Reactive Arthritis (Reiter's Syndrome)

Rheumatoid Arthritis

Rheumatoid Vasculitis

Still's Disease

Systemic Lupus Erythematosus (SLE)

Systemic Vasculitis

Takayasu Arteritis

Temporal Arteritis (Giant cell arteritis)

Vasculitis (Angiitis)

Weill-Marchesani Syndrome

Peer Reviewed Publications

Onuorah, Nneoma; Abraham, Hrudya; Vashisht, Priyanka 2020. The Diagnostic Conundrum of Felty Syndrome and T-Cell Large Granular Lymphocytic Leukemia. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, ,

Vashisht, Priyanka; O'dell, James 2017. Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differences. Expert opinion on biological therapy, 17 8, 989-999

Vashisht P.;Sayles H.;Cannella A.;Mikuls T.;Michaud K. 10-01-2016. Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical Trials Arthritis Care and Research, 68 10, 1478-1488

Wampler Muskardin T.;Vashisht P.;Dorschner J.M.;Jensen M.A.;Chrabot B.S.;Kern M.;Curtis J.R.;Danila M.I.;Cofield S.S.;Shadick N.;Nigrovic P.A.;St Clair E.W.;Bingham C.O.;Furie R.;Robinson W.;Genovese M.;Striebich C.C.;O'Dell J.R.;Thiele G.M.;Moreland L.W.;Levesque M.;Bridges S.L.;Gregersen P.K.;Niewold T.B. 10-01-2016. Increased pretreatment serum IFN-?/? ratio predicts non-response to tumour necrosis factor ? inhibit Annals of the rheumatic diseases, 75 10, 1757-1762

Vashisht P.;Borghoff K.;O'Dell J.;Hearth-Holmes M. 07-01-2017. Belimumab for the treatment of recalcitrant cutaneous lupus Lupus, 26 8, 857-864

Vashisht P.;Casale T. 01-01-2013. Omalizumab for treatment of allergic rhinitis Expert Opinion on Biological Therapy, 13 6, 933-945